Data demonstrated a numerical treatment benefit across multiple efficacy measures ... the significant unmet medical needs of patients with chronic, non-healing diabetic ulcers." ...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the ...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the secon ...

BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment October 15, 2024: BioStem Technologies Establishes ...

Diabetologists stress importance of proper knowledge, cooperation with doctors, and debunk myths in diabetes management.

The company has also made strategic strides with the nationwide launch of Vendaje AC® and the publication of breakthrough clinical data in diabetic foot ulcer treatment, further solidifying its market ...

In the lower limbs, poor blood flow, slow healing and nerve damage (neuropathy) can result in diabetic foot ulcers, ...

Diabetes mellitus is a chronic medical condition characterized by elevated blood sugar levels, primarily due to a deficiency ...

When taking weight loss medications, eating nutritious foods and getting physical activity are key to staying well for people with diabetes. Brief bouts of exercise can help build and maintain ...